ArticleDrug delivery and translational research2026

Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2.

Yuan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.